Recent Finacing
Recent Raise
Tempero Bio is a clinical biopharmaceutical developing TMP-301, an mGluR5 NAM, with Phase 2 alcohol trials, DDI study and planned Phase 2 in cocaine, and PET-confirmed Phase 1 data.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Tempero Bio.
